A lack of genetic diversity in genomic research poses a significant threat to the future equitability of precision medicine (1). Genetic studies predominantly focus on groups of European ancestry – but a new African initiative is set to encourage translational genomics research in an area frequently overlooked. By providing grants, fellowships, internships, and training for researchers and trainees, the African Centre for Translational Genomics (ACTG) aims to empower the next generation of African scientists.
Its first project, the Non-Communicable Diseases – Genetic Heritage Study (NCD-GHS), will recruit over 100,000 Nigerians to better understand the genetic basis of highly prevalent NCDs, such as diabetes and chronic kidney disease, within the nation. “The NCD-GHS has the potential to rewrite the playbook of genomics research, where African scientists will be at the forefront of new discoveries for conditions that affect Nigerians and people worldwide,” said Abasi Ene-Obong, CEO of 54gene, the company behind the ACTG (2).
References
The Pathologist (2019). Available at: https://bit.ly/2Top7j2.
Press Release (2020). Available at: https://bit.ly/2PNwTRc.